Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$333K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Sep 9 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 3,194 | — | — | — | Open the original filing on SEC.gov |
| Sep 9 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 2,154 | $154.61 | $333K | -3.2% | Open the original filing on SEC.gov |
| Sep 9 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 3,194 | $43.24 | $138.1K | +5.0% | Open the original filing on SEC.gov |
| May 11 | ATYR | aTYR PHARMA INC | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 6,365 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT◆ | 36,287 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,083 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 1,961 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 8,963 | $124.12 | $1.1M | -12.4% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 16,613 | — | — | +29.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,124 | $124.12 | $139.5K | -2.0% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,083 | — | — | +3.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,058 | $124.12 | $131.3K | -1.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 1,961 | — | — | +3.6% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,005 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 1,082 | $123.10 | $133.2K | -2.0% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 2,005 | — | — | +3.8% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,294 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 1,292 | $136.06 | $175.8K | -2.4% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 2,294 | — | — | +4.4% | Open the original filing on SEC.gov |
| Nov 28, 2025 | NBIX | Neurocrine Biosciences INC | MEXER◆↺ | 12,830 | — | — | — | Open the original filing on SEC.gov |
| Nov 28, 2025 | NBIX | Neurocrine Biosciences INC | MEXER↺ | 12,830 | $35.99 | $461.8K | +28.6% | Open the original filing on SEC.gov |
| May 1, 2025 | ATYR | aTYR PHARMA INC | AGRANT◆ | 50,000 | — | — | — | Open the original filing on SEC.gov |